<SEC-DOCUMENT>0001493152-24-022329-index.html : 20240603
<SEC-HEADER>0001493152-24-022329.hdr.sgml : 20240603
<ACCEPTANCE-DATETIME>20240603101524
ACCESSION NUMBER:		0001493152-24-022329
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20240531
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240603
DATE AS OF CHANGE:		20240603

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AIM ImmunoTech Inc.
		CENTRAL INDEX KEY:			0000946644
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				520845822
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-27072
		FILM NUMBER:		241012328

	BUSINESS ADDRESS:	
		STREET 1:		2117 SW HIGHWAY 484
		CITY:			OCALA
		STATE:			FL
		ZIP:			32801
		BUSINESS PHONE:		352-448-7797

	MAIL ADDRESS:	
		STREET 1:		2117 SW HIGHWAY 484
		CITY:			OCALA
		STATE:			FL
		ZIP:			32801

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEMISPHERX BIOPHARMA INC
		DATE OF NAME CHANGE:	19950614
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
Document 1 - file: form8-k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1.1 <SEQUENCE>2 <FILENAME>ex1-1.htm <TEXT> Document 2 - file: ex1-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.1 <SEQUENCE>3 <FILENAME>ex4-1.htm <TEXT> Document 3 - file: ex4-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>4 <FILENAME>ex5-1.htm <TEXT> Document 4 - file: ex5-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>5 <FILENAME>ex10-1.htm <TEXT> Document 5 - file: ex10-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>6 <FILENAME>ex99-1.htm <TEXT> Document 6 - file: ex99-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.SCH <SEQUENCE>7 <FILENAME>aim-20240531.xsd <DESCRIPTION>XBRL SCHEMA FILE <TEXT> Document 7 - file: aim-20240531.xsd
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.LAB <SEQUENCE>8 <FILENAME>aim-20240531_lab.xml <DESCRIPTION>XBRL LABEL FILE <TEXT> Document 8 - file: aim-20240531_lab.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.PRE <SEQUENCE>9 <FILENAME>aim-20240531_pre.xml <DESCRIPTION>XBRL PRESENTATION FILE <TEXT> Document 9 - file: aim-20240531_pre.xml
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>11 <FILENAME>R1.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 11 - file: R1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EXCEL <SEQUENCE>12 <FILENAME>Financial_Report.xlsx <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 12 - file: Financial_Report.xlsx
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>13 <FILENAME>Show.js <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 13 - file: Show.js
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>14 <FILENAME>report.css <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 14 - file: report.css
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>16 <FILENAME>FilingSummary.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 16 - file: FilingSummary.html
Document 16 - RAW XML: FilingSummary.xml
</DOCUMENT> <DOCUMENT> <TYPE>JSON <SEQUENCE>18 <FILENAME>MetaLinks.json <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 18 - file: MetaLinks.json
</DOCUMENT> <DOCUMENT> <TYPE>ZIP <SEQUENCE>19 <FILENAME>0001493152-24-022329-xbrl.zip <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 19 - file: 0001493152-24-022329-xbrl.zip
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>21 <FILENAME>form8-k_htm.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 21 - file: form8-k_htm.html
Document 21 - RAW XML: form8-k_htm.xml
</DOCUMENT> </SEC-DOCUMENT>